期刊文献+

Ⅲ型糖原累积症的临床特点分析 被引量:6

Clinical analysis of 50 cases of glycogen storage disease type Ⅲ
暂未订购
导出
摘要 目的分析Ⅲ型糖原累积症的临床特点。方法回顾分析1990-01~2010-01收治的50例Ⅲ型糖原累积症(gly-cogen storage disease typeⅢ,GSDⅢ)的临床资料。结果 50例GSDⅢ型患儿分布于全国20个省市,男36例,女14例;出现症状平均年龄为(1.2±0.9)岁,就诊平均年龄为(5.1±4.1)岁。50例(100%)GSDⅢ型患儿均有低血糖、肝脏肿大、肝功异常和肾上腺素刺激试验符合GSDⅢ,45例(90.0%)出现脾脏肿大,36例(72.0%)出现身材矮小,19例(38.0%)出现骨龄落后,25例(50.0%)出现肌无力,16例(32.0%)出现心脏肥大,50例(100%)肾脏均不肿大,34例(68.0%)出现代谢性酸中毒,30例(60.0%)出现高血脂,35例(70.0%)出现心肌酶高。42例患儿(84.0%)肝穿病理提示肝脏内有大量糖原堆积,未见肝纤维化。结论Ⅲ型糖原累积症是小儿较常见的遗传代谢病之一,临床表现差异较大,及早诊断治疗有可能改善小儿生存质量和预后。 Objective To analyze the clinical characteristics of glycogen storage disease type Ⅲ(GSD Ⅲ).Methods The clinical data of 50 children diagnosed as glycogen storage disease type Ⅲ from January 1990 to January 2010 were retrospectively analyzed.Results All 50 children,36 male and 14 female,aged(5.1±4.1)years,showed hypoglycemia,hepatomegaly,liver dysfunction,and no renomegaly,and epinephrine stimulation test consistent with GSD Ⅲ.Of 50 children,45(90.0%) showed splenomegaly,36(72.0%) for microsomia,19(38.0%) for bone age lag,25(50.0%) for myasthenia,16(32.0%) for cardiac hypertrophy,34(68.0%) for metabolic acidosis,30(60.0%) for hyperlipemia,35(70.0%) for raised creatin kinase.Liver puncture biopsy showed obvious glyogen storage in the liver of 42 chilren,but no fibrosis.Conclusion Glycogen storage disease type Ⅲ is one of the common pediatric metabolic diseases,and has obviously different clinical manifestation.Prompt diagnosis and treatment will improve the prognosis and the life quality.
作者 庄太凤 魏珉
出处 《山西医科大学学报》 CAS 2011年第2期132-134,共3页 Journal of Shanxi Medical University
基金 国家自然科学基金资助项目(30900803)
关键词 Ⅲ型糖原累积症 低血糖 肝脏肿大 肾上腺素刺激试验 glycogen storage disease type Ⅲ hypoglycemia hepatomegaly epinephrine stimulation test
  • 相关文献

参考文献9

  • 1Oh SH,Park HD,Ki CS,et al.Biochemical and molecular investigation of two Korean patients with glycogen storage disease type Ⅲ[J].Clin Chem Lab Med,2008,46(9):1245-1249.
  • 2Endo Y,Horinishi A,Vorgerd M,et al.Molecular analysis of the AGL gene:heterogeneity of mutations in patients with glycogen storage disease type Ⅲ from Germany,Canada,Afghanistan,Iran,and Turkey[J].J Hum Genet,2006,51(11):958-963.
  • 3Endo Y,Fateen E,Aoyama Y,et al.Molecular characterization of Egyptian patients with glycogen storage disease type Ⅲa[J].J Hum Genet,2005,50(10):538-542.
  • 4Bhatti S,Parry E.Successful pregnancy in a woman with glycogen storage disease type Ⅲ[J].Aust N Z J Obstet Gynaecol,2006,46(2):168-169.
  • 5Zimakas PJ,Rodd CJ.Glycogen storage disease type Ⅲ in Inuit children[J].Can Med Assoc J,2005,172(3):355-358.
  • 6Endo Y,Fateen E,El Shabrawy M,et al.Egyptian glycogen storage disease type Ⅲ-identification of six novel AGL mutations,including a large 1.5 kb deletion and a missense mutation p.L620P with subtype Ⅲd[J].Clin Chem Lab Med,2009,47(10):1233-1238.
  • 7Chen Y,Burchell TA.Glycogen storage disease[M] //Scriver CR,Beaudet AL,Sly WS,et al.The Metabolic and Molecular Bases of Inherited Disease.10 th ed.New York:McGraw-Hill,2001:1530-1551.
  • 8Lam CW,Lee AT,Lam YY,et al.DNA-based subtyping of glycogen storage disease type Ⅲ:mutation and haplotype analysis of the AGL gene in Chinese[J].Mol Genet Metab,2004,83(3):271-275.
  • 9Yuan-Tsong Chen.Glycogen storage diseases[M] //Behrman RE,Kliegman RM,Jenson HB eds.The Nelson Textbook of Pediatrics.17th ed.Philadelphia:W.B.Saunders Company,2004:469-475.

同被引文献85

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部